ADC Therapeutics SA (ADCT) Insider Trading
- $1,428,000.00
- $8,502,619.55
- April 2, 2026
- Redmile Group, Llc
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| April 2, 2026 | Major Shareholder | 2,529,491 | $3.28 | Sell | $8,296,730.48 | |
| Dec. 11, 2024 | Major Shareholder | 100,000 | $3.04 | Buy | $304,000.00 | |
| Dec. 4, 2024 | Major Shareholder | 25,352 | $2.07 | Sell | $52,478.64 | |
| July 1, 2024 | Major Shareholder | 400,000 | $2.81 | Buy | $1,124,000.00 | |
| June 17, 2024 | Director | 6,995 | $2.89 | Sell | $20,215.55 | |
| May 7, 2024 | CEO | 29,731 | $4.48 | Sell | $133,194.88 |
Insiders are both buying and selling ADC Therapeutics SA stock.
The insider traders at ADC Therapeutics SA are: Redmile Group, Llc, Ameet Mallik, and Robert Azelby
The most active insider trader at ADC Therapeutics SA is Redmile Group, Llc with 4 trades.
Redmile Group, Llc has sold the most ADC Therapeutics SA stock with a total value of $16,645,939.60.
Redmile Group, Llc has bought the most ADC Therapeutics SA stock with a total value of $1,732,000.00.
The most recent insider trade for ADC Therapeutics SA was on April 2, 2026.
The single biggest insider buy for ADC Therapeutics SA was from Redmile Group, Llc with a total value of $1,124,000.00 on July 1, 2024.
The single biggest insider sell for ADC Therapeutics SA was from Redmile Group, Llc with a total value of $8,296,730.48 on April 2, 2026.